HOB BIOTECH(SH:688656) Zheng Quan Zhi Xing·2025-08-14 16:39Meeting Details - The 19th meeting of the third Supervisory Board of Jiangsu Haoaobo Biopharmaceutical Co., Ltd. was held on August 13, 2025, with all three supervisors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1] Financial Report Review - The Supervisory Board reviewed the company's 2025 semi-annual report, confirming that its preparation and review procedures comply with relevant laws and internal management regulations [1] - The report accurately reflects the company's financial status and operating results for the first half of 2025, with all members of the Supervisory Board ensuring the information disclosed is true, accurate, and complete [1] Fund Management - The Supervisory Board assessed the management of raised funds, confirming compliance with the regulations governing the management of raised funds and the company's fundraising management system [2] - The company has stored and utilized the raised funds in a dedicated account, with no violations or damages to the interests of the company and its shareholders [2] Auditor Appointment - The Supervisory Board approved the appointment of Ernst & Young Hua Ming LLP as the auditing firm for the company's 2025 financial report and internal control audit, citing their qualifications and experience [3] - The resolution received unanimous approval from all supervisors, with 100% of the voting rights in favor [3]